BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vázquez R, García P. Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae. Front Microbiol 2019;10:1251. [PMID: 31231338 DOI: 10.3389/fmicb.2019.01251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Schmelcher M, Loessner MJ. Bacteriophage endolysins - extending their application to tissues and the bloodstream. Curr Opin Biotechnol 2021;68:51-9. [PMID: 33126104 DOI: 10.1016/j.copbio.2020.09.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Liu S, Lu H, Zhang S, Shi Y, Chen Q. Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review. Pharmaceutics 2022;14:427. [DOI: 10.3390/pharmaceutics14020427] [Reference Citation Analysis]
3 Fernández L, Cima-Cabal MD, Duarte AC, Rodríguez A, García-Suárez MDM, García P. Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy. Antibiotics (Basel) 2021;10:1000. [PMID: 34439050 DOI: 10.3390/antibiotics10081000] [Reference Citation Analysis]
4 Caflisch KM, Suh GA, Patel R. Biological challenges of phage therapy and proposed solutions: a literature review. Expert Rev Anti Infect Ther 2019;17:1011-41. [PMID: 31735090 DOI: 10.1080/14787210.2019.1694905] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
5 Ho MKY, Zhang P, Chen X, Xia J, Leung SSY. Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies. Crit Rev Microbiol 2021;:1-24. [PMID: 34478359 DOI: 10.1080/1040841X.2021.1962803] [Reference Citation Analysis]
6 Gondil VS, Harjai K, Chhibber S. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 2020;55:105844. [PMID: 31715257 DOI: 10.1016/j.ijantimicag.2019.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
7 Cools F, Delputte P, Cos P. The search for novel treatment strategies for Streptococcus pneumoniae infections. FEMS Microbiol Rev 2021:fuaa072. [PMID: 33399826 DOI: 10.1093/femsre/fuaa072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Silva MD, Oliveira H, Faustino A, Sillankorva S. Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1. Biotechnol Rep (Amst) 2020;28:e00547. [PMID: 33204659 DOI: 10.1016/j.btre.2020.e00547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Tian F, Li J, Nazir A, Tong Y. Bacteriophage - A Promising Alternative Measure for Bacterial Biofilm Control. Infect Drug Resist 2021;14:205-17. [PMID: 33505163 DOI: 10.2147/IDR.S290093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kim S, Jin J, Lee D, Kim J. Antibacterial activities of and biofilm removal by Ablysin, an endogenous lysozyme-like protein originated from Acinetobacter baumannii 1656-2. Journal of Global Antimicrobial Resistance 2020;23:297-302. [DOI: 10.1016/j.jgar.2020.09.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vázquez R, Blanco-Gañán S, Ruiz S, García P. Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties. Front Microbiol 2021;12:660403. [PMID: 34113327 DOI: 10.3389/fmicb.2021.660403] [Reference Citation Analysis]
12 Dietl B, Henares D, Boix-Palop L, Muñoz-Almagro C, Garau J, Calbo E. Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome. Front Med (Lausanne) 2021;8:650271. [PMID: 33996857 DOI: 10.3389/fmed.2021.650271] [Reference Citation Analysis]
13 Rahman MU, Wang W, Sun Q, Shah JA, Li C, Sun Y, Li Y, Zhang B, Chen W, Wang S. Endolysin, a Promising Solution against Antimicrobial Resistance. Antibiotics (Basel) 2021;10:1277. [PMID: 34827215 DOI: 10.3390/antibiotics10111277] [Reference Citation Analysis]
14 van der Kamp I, Draper LA, Smith MK, Buttimer C, Ross RP, Hill C. A New Phage Lysin Isolated from the Oral Microbiome Targeting Streptococcus pneumoniae. Pharmaceuticals (Basel) 2020;13:E478. [PMID: 33352708 DOI: 10.3390/ph13120478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Bocian A, Ciszkowicz E, Hus KK, Buczkowicz J, Lecka-Szlachta K, Pietrowska M, Petrilla V, Petrillova M, Legáth Ľ, Legáth J. Antimicrobial Activity of Protein Fraction from Naja ashei Venom Against Staphylococcus epidermidis. Molecules 2020;25:E293. [PMID: 31936872 DOI: 10.3390/molecules25020293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wang F, Xiao Y, Xiong Y, Jiao Y, Zhang Q, Lin L. Complete genome sequence of MMP7, a novel Meiothermus bacteriophage of the family Myoviridae isolated from a hot spring. Arch Virol 2020;165:753-6. [PMID: 31965314 DOI: 10.1007/s00705-019-04462-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Linden SB, Alreja AB, Nelson DC. Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives. Curr Opin Biotechnol 2021;68:213-20. [PMID: 33529969 DOI: 10.1016/j.copbio.2021.01.012] [Reference Citation Analysis]
18 Vázquez R, García E, García P. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design. J Virol 2021;95:e0032121. [PMID: 33883227 DOI: 10.1128/JVI.00321-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]